Wolfe Research Upgrades Kymera Therapeutics (KYMR) to Outperform
Tweet Send to a Friend
(Updated - August 26, 2024 6:03 AM EDT)
Wolfe Research analyst Andy Chen upgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wolfe Research analyst Andy Chen upgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
